These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25463086

  • 1. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX, Li XL, Zhang MZ, Guo YL, Zhu CG, Guo LH, Li S, Zhang Y, Li JJ.
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [Abstract] [Full Text] [Related]

  • 2. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [Abstract] [Full Text] [Related]

  • 3. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL, Guo YL, Zhu CG, Xu RX, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL, Li JJ.
    J Am Heart Assoc; 2015 Jan 08; 4(1):e001412. PubMed ID: 25572484
    [Abstract] [Full Text] [Related]

  • 4. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX, Li S, Zhang MZ, Li XL, Zhu CG, Guo YL, Zhang Y, Li JJ.
    J Cardiol; 2017 Aug 08; 70(2):113-120. PubMed ID: 28209463
    [Abstract] [Full Text] [Related]

  • 5. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
    Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL.
    J Clin Lipidol; 2014 Aug 08; 8(4):423-32. PubMed ID: 25110224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
    Buturak A, Degirmencioglu A, Erturk M, Karakurt H, Demir AR, Surgit O, Pusuroglu H, Akgul O, Serteser M, Norgaz T, Gorgulu S.
    Coron Artery Dis; 2015 Jun 08; 26(4):333-40. PubMed ID: 25714068
    [Abstract] [Full Text] [Related]

  • 8. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
    Zhong Z, Liu J, Zhang Q, Zhong W, Li B, Li C, Liu Z, Yang M, Zhao P.
    Med Sci Monit; 2018 Jun 18; 24():4154-4161. PubMed ID: 29910459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.
    Am J Cardiol; 2012 Nov 15; 110(10):1397-404. PubMed ID: 22858186
    [Abstract] [Full Text] [Related]

  • 11. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A, Ando H, Takashima H, Kumagai S, Kurita A, Waseda K, Suzuki Y, Mizuno T, Harada K, Uetani T, Takahashi H, Yoshikawa D, Ishii H, Murohara T, Amano T.
    EuroIntervention; 2014 Nov 15; 10(7):792-8. PubMed ID: 25415148
    [Abstract] [Full Text] [Related]

  • 12. Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention.
    Wang Y, Zhang HW, Guo YL, Zhu CG, Wu NQ, Li JJ.
    Postgrad Med J; 2019 Jan 15; 95(1119):18-22. PubMed ID: 30700582
    [Abstract] [Full Text] [Related]

  • 13. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY, Qiao SB, Zhang JF, Dong QT, Li JJ.
    Coron Artery Dis; 2012 May 01; 23(3):181-7. PubMed ID: 22336660
    [Abstract] [Full Text] [Related]

  • 16. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Schaffer A, Barbieri L, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Atherosclerosis; 2014 Sep 01; 236(1):169-74. PubMed ID: 25055060
    [Abstract] [Full Text] [Related]

  • 17. LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Liu YH, Liu Y, Chen JY, Zhou YL, Chen ZJ, Yu DQ, Luo JF, Li HL, He YT, Ye P, Ran P, Guo W, Tan N.
    Atherosclerosis; 2014 Dec 01; 237(2):453-9. PubMed ID: 25463073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.